Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Amino-ketones from Roche found to lower cholesterol levels in animals

April 25, 1997

NovaDx discovers osteoporosis drug opportunities

April 25, 1997

Potent, orally active ACAT inhibitors from Sankyo

April 24, 1997

Azko Nobel discloses antiglucocorticoids

April 24, 1997

Antioxidants/hypolipidemics from ADIR

April 24, 1997

Ono discloses ICE inhibitors

April 23, 1997

New agents for postmenopausal syndrome described by Lilly

April 23, 1997

Gensia Sicor and Sankyo collaborate in diabetes research

April 22, 1997

New selective estrogen receptor modulator from Lilly

April 22, 1997

Pfizer discovers potent, selective beta3-adrenoceptor full agonist

April 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...